Share buy-back

Share buy-back 2019

On March 11, 2019 we announced to commence our share buy-back program on the basis of the authorization by the General Meeting 2016.

In the context of this share buy-back program, the company repurchased 3.7 million ordinary shares at a total purchase price (excluding ancillary transaction costs) of 270 million Euro in the period from 12 March 2019 until and including 10 May 2019.

Up to a maximum of 12 million ordinary shares will be repurchased at a total purchase price (excluding ancillary transaction costs) of up to 660 million Euro (approximately 745 million U.S. Dollar) in the period from 17 June 2019 until and including 17 June 2020.

The own shares repurchased by the Company will be used for the sole purpose of reducing the registered share capital by cancellation of the repurchased own shares.

In the following, we inform you about the progress of the share buy-back program.

Period	Acquired shares (number)	Average price (in €)	Purchased volume (in €)	Details (overview)
June 17-21, 2019	268,881	69.4151	18,539,371.60	CW 25
June 24-28, 2019	235,791	68.6900	16,202,459.86	CW 26
July 1-5, 2019	191,565	70.6451	13,531,851.27	CW 27
July 8-12, 2019	234.300	68.9617	16,008,564.21	CW 28
July 15-19, 2019	313,690	68.9307	21,482,477.74	CW 29
July 22-26, 2019	226,354	67.9923	15,365,657.14	CW 30
July 29 - August 2, 2019	63,746	65.9749	4,186,086.59	CW 31
August 5-9, 2019	99,453	60.1077	5,982,894.14	CW 32
August 12-16, 2019	297,998	59.3147	17,657,467.50	CW 33
August 19-23, 2019	258,000	60.6767	15,677,626.01	CW 34
August 26-30, 2019	179,757	60.6304	10,898,390.31	CW 35
September 2-6, 2019	216,466	61.5136	13,299,110.45	CW 36
September 9-13, 2019	238,000	62.5762	14,877,752.80	CW 37
September 16-20, 2019	173,000	63.3081	10,951,978.68	CW 38
September 23-27, 2019	-	-	-	CW 39
September 30 - October 4, 2019	-	-	-	CW 40
October 7-11, 2019	113,498	59.2132	6,746,695.83	CW 41
October 14-18, 2019	205,025	60.9088	12,549,505.19	CW 42
October 21-25, 2019	329,490	59.8711	19,192,556.07	CW 43
October 28 - November 1, 2019	81,721	65.2578	5,328,059.92	CW 44
November 4-8, 2019	177,000	67.8643	12,010,538.75	CW 45
November 11-15, 2019	174,687	66.2944	11,580,925.97	CW 46
November 18-22, 2019	174,731	66.7549	11,663,941.42	CW 47
November 25-29, 2019	289,617	66.7641	19,306,343.34	CW 48
December 2-6, 2019	186,894	65.7546	12,289,499.59	CW 49
December 9-13, 2019	189,170	64.4820	12,886,319.87	CW 50
December 16-20, 2019	188,844	65.0585	12,283,796.78	CW 51
December 23-27, 2019	-	-	-	CW 52
December 30, 2019 - January 3, 2020	-	-	-	CW 01
January 6-10, 2020	85,000	65.5289	5,570,318.00	CW 02
January 13-17, 2020	35,000	66,3875	2,323,563.90	CW 03
Total	5,227,678	64.8103	337,893,752.98

Period	Acquired shares (number)	Average price (in €)	Purchased volume (in €)	Details (overview)
March 12-15, 2019	550,000	69.36646	38,151,553.00	CW 11
March 18-22, 2019	734,693	69.81767	51,294,556.71	CW 12
March 25-29, 2019	344,547	70.72767	24,369,006.52	CW 13
April 01-05, 2019	433,128	73.67726	31,911,683.99	CW 14
April 08-12, 2019	497,677	73.72803	36,692,744.84	CW 15
April 15-18, 2019	809,692	71.94412	58,252,578.36	CW 16
April 23-26, 2019	192,031	71.71234	13,770,991.54	CW 17
April 29 - May 3, 2019	111,494	74.99443	8,361,430.03	CW 18
May 6-10, 2019	97,510	73.79218	7,195,475.25	CW 19
Total	3,770,772	71.60338	270,000,020.24

Adhoc News from February 20, 2019

Announcement on share buy-back from June 14, 2019

Announcement on share buy-back from March 11, 2019

Share buy-back 2018

On May 25, 2018 we announced to commence our share buy-back program on the basis of the authorization by the General Meeting 2016.

In the context of this share buy-back program, up to a maximum of 431,000 ordinary shares of Fresenius Medical Care will be repurchased at a total purchase price (excluding ancillary transaction costs) of up to 39 million Euro (approximately 46.5 million U.S. Dollar) in the period from May 28, 2018 until and including June 20, 2018.

In the following, we inform you about the progress of the share buy-back program.

The own shares repurchased by the Company will be used for the sole purpose of reducing the registered share capital by cancellation of the repurchased own shares in order to neutralize the dilution from the Stock Option Plan 2011.

Period	Acquired shares (number)	Average price (in €)	Purchased volume (in €)	Details (overview)
May 28, 2018	43,274	86.8348	3,758,816.44	CW 22
May 29, 2018	43,500	86.4675	3,762,464.65	CW 22
May 30, 2018	43,500	87.0162	3,786,340.26	CW 22
May 31, 2018	43,000	86.3560	3,714,421.99	CW 22
June 1, 2018	44,500	85.1607	3,790,788.05	CW 22
June 4, 2018	43,500	85.3555	3,712,964.25	CW 23
June 5, 2018	43,500	86.6331	3,768,539.85	CW 23
June 6, 2018	42,294	86.7213	3,667,790.66	CW 23
June 7, 2018	42,863	86.7374	3,717,825.18	CW 23
June 8, 2018	41,069	86.3573	3,546,607.95	CW 23
Total	431,000	86.3828	37,230,979.89

Announcement on share buy-back from May 25, 2018

Share buy-back 2017

On December 8, 2017 we announced to commence our share buy-back program on the basis of the authorization by the General Meeting 2016.

In the context of this share buy-back program, up to a maximum of 660,000 ordinary shares of Fresenius Medical Care will be repurchased at a total purchase price (excluding ancillary transaction costs) of up to 61 million Euro (approximately 72 million U.S. Dollar) in the period from December 11, 2017 until and including December 22, 2017.

In the following, we inform you about the progress of the share buy-back program.

Period	Acquired shares (number)	Average price (in €)	Purchased volume (in €)	Details (overview)
December 11, 2017	90,000	87.4549	7,870,941.00	CW 50
December 12, 2017	89,582	88.0422	7,886,996.36	CW 50
December 13, 2017	90,000	88.6892	7,982,028.00	CW 50
December 14, 2017	83,993	87.5675	7,355,057.03	CW 50
December 15, 2017	85,000	86.7878	7,376,963.00	CW 50
December 18, 2017	74,879	88.2222	6,605,990.11	CW 51
December 19, 2017	74,389	87.9080	6,539,388.21	CW 51
December 20, 2017	74,403	87.5432	6,250,847.11	CW 51
December 21, 2017	754	87.2622	65,795.70	CW 51
Total	660,000	87.7788	57,934,006.52

Announcement on share buy-back from December 8, 2017

Share buy-back 2013

On May 20, 2013 we commenced, as announced on May 17, 2013, our share buy-back program on the basis of the authorization by the Annual General Meeting 2011.

In the context of this share buy-back program, ordinary shares of Fresenius Medical Care in the total amount of €385 million (excluding fees) were repurchased in the period from May 20, 2013 until August 14, 2013. Accordingly, the share buy-back program was fully completed on August 14, 2013. The program was financed from cash flow and existing credit facilities.

In the following we inform you about the number of shares acquired in the context of the share buy-back program.

The own shares acquired by the company will be used to serve the sole purposes of either reducing the registered share capital of the company by cancellation of the acquired own shares, or fulfilling employee participation programs of the company.

Period	Acquired shares (number)	Average price (in €)	Purchased volume (in €)	Details (overview)
August 12 - 14, 2013	184,054	49.6011	9,092,291	KW33
August 5 - 9, 2013	556,951	48.2319	26,853,458	KW 32
July 29 - August 2, 2013	683,469	47.8786	32,713,578	KW 31
July 22 - 26, 2013	605,718	49.4679	29,967,517	KW 30
July 15 - 19, 2013	597,667	49.8732	29,803,999	KW 29
July 8 - 12, 2013	674,990	49.4151	33,329,905	KW 28
July 1 - 5, 2013	665,295	50.2787	33,288,492	KW 27
June 24 - 28, 2013	646,000	53.9658	34,859,615	KW 26
June 17 - 21, 2013	580,752	53.2386	30,934,815	KW 25
June 10 - 14, 2013	642,038	52.9178	33,974,663	KW 24
June 3 - 7, 2013	633,762	52.0384	32,976,696	KW 23
May 27 - 31, 2013	582,730	52.7636	30,728,800	KW 22
May 20 - 24, 2013	495,525	53.1082	26,360,719	KW 21
Total	7,548,951	51.00	384,884,547